Solutions
Solutions

R&D Teams

Regulatory Teams

Commercial Teams

HEOR Teams

Cancer Centers and Oncologists
Products
Products

Focus

Vantage

Vista

Clinicogenomics

Real-World Analytics
Services
Services

Real-World Insights & Support
About Us
About Us

Our Mission

Careers
Resources
Resources

Research

Blog

News

Podcasts

Case Studies

Extending COTA’s global reach with RWD in oncology research

Read More

3 key takeaways from ASCO 2025: Staying nimble in a changing environment

Read More

Vantage

Clinical Insight for Your Entire Organization

Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.

Use Cases

Make Better Decisions Across Therapy Lifecycle

From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.

Pre-Marketing

Inform R&D strategy, optimize trial design, or create an ECA to support regulatory submission.

Commercial and Post-Marketing

Conduct Phase IV and HEOR studies and optimize commercial strategy.

COTA by the Numbers

2.1M+ Cancer Patient Lives

50/50 Academic vs. Community Treatment Setting

3 Approvals Supported

9 Hematology and Solid Tumor Diagnoses

5-Year Average Follow-up

2X Higher Inclusion Percentage in ECA vs. Competitor

Quality Real-World Data for Hematologic and Solid Tumor Diagnoses

COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:

Heme/Onc:

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Follicular Lymphoma

Marginal Zone Lymphoma

Multiple Myeloma

Myelodysplastic Syndrome

Small Lymphocytic Lymphoma

Mantle Cell Lymphoma

Solid Tumors:

Breast Cancer

Colon Cancer

Rectal Cancer

Gastric Cancer

Lung Cancer

Melanoma

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

Additional Support

Get the Most of Your Vantage Data with Real-World Insights and Support

Real-World Insights and Support is an optional add-on that pairs perfectly with your Vantage data. Our team of clinical experts, researchers, and statisticians will come alongside your teams to help them use the data to design studies, run analyses, and construct regulatory submission packages.

Resources

Fueling the Future of Cancer Research

Explore our collection of clinical research, recent press, podcasts, and more.

Extending COTA’s global reach with RWD in oncology research

Cancer is a disease that respects no borders: it affects everyone around the world, no matter where they live. The...

3 key takeaways from ASCO 2025: Staying nimble in a changing environment

3 key takeaways from ASCO 2025: Staying nimble in a changing environment The annual meeting of the American Society of...

Reflections on ISPOR: Shifting data dynamics open new opportunities for RWD and RWE

Each year, ISPOR brings together members of the health economics and outcomes research (HEOR) community for a celebration of the...

Get a Better View with Vantage

Discover the power of real-world cancer data for your life science organization.

Solutions

Products

Services

About Us

Resources

Extending COTA’s global reach with RWD in oncology research

3 key takeaways from ASCO 2025: Staying nimble in a changing environment

Vantage

Clinical Insight for Your Entire Organization

Use Cases

Make Better Decisions Across Therapy Lifecycle

Pre-Marketing

Commercial and Post-Marketing

COTA by the Numbers

2.1M+ Cancer Patient Lives

50/50 Academic vs. Community Treatment Setting

3 Approvals Supported

9 Hematology and Solid Tumor Diagnoses

5-Year Average Follow-up

2X Higher Inclusion Percentage in ECA vs. Competitor

Quality Real-World Data for Hematologic and Solid Tumor Diagnoses

Heme/Onc:

Solid Tumors:

Additional Support

Get the Most of Your Vantage Data with Real-World Insights and Support

Resources

Fueling the Future of Cancer Research

Extending COTA’s global reach with RWD in oncology research

3 key takeaways from ASCO 2025: Staying nimble in a changing environment

Reflections on ISPOR: Shifting data dynamics open new opportunities for RWD and RWE

Get a Better View with Vantage

Solutions

Products & Services

About Us

Follow Us